BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 6380902)

  • 1. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR
    Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro properties of ceftazidime, a highly active broad-spectrum cephalosporin with antipseudomonal activity.
    Harper PB
    Clin Ther; 1984; 6(4):411-24. PubMed ID: 6432324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their monobactam analogs].
    Baumgärtner M
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Apr; 254(2):253-60. PubMed ID: 6326420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipseudomonal activities of new cephem antibiotics].
    Ohkoshi M
    Hinyokika Kiyo; 1984 Apr; 30(4):437-48. PubMed ID: 6435413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa].
    Kawamura N; Ohkoshi M; Okada K; Kumamoto Y; Miyamoto S; Niijima T; Kishi Y; Nishimura Y; Saito I; Yuge J
    Hinyokika Kiyo; 1983 Sep; 29(9):1147-88. PubMed ID: 6375316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
    Nichols L; Maki DG
    Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cefsulodin, a new antibiotic of the group of cephalosporins: its action on Pseudomonas aeruginosa (author's transl)].
    Segura C; Foz A; Fuster C; Tirado M; Roy C
    Med Clin (Barc); 1981 Jun; 77(2):50-5. PubMed ID: 6798336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third generation cephalosporins.
    Donowitz GR
    Infect Dis Clin North Am; 1989 Sep; 3(3):595-612. PubMed ID: 2671141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefepime: a new fourth-generation cephalosporin.
    Okamoto MP; Nakahiro RK; Chin A; Bedikian A; Gill MA
    Am J Hosp Pharm; 1994 Feb; 51(4):463-77; quiz 541-2. PubMed ID: 8017411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime, a broad spectrum cephalosporin with activity against Ps. aeruginosa.
    O'Callaghan H
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(4):449-53. PubMed ID: 3100612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftazidime and cefotaxime--the clinician's choice.
    Puthucheary SD; Goldsworthy PJ
    Clin Ther; 1989; 11(2):186-204. PubMed ID: 2660995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefuroxime: mechanisms of action, antimicrobial activity, pharmacokinetics, clinical applications, adverse reactions and therapeutic indications.
    Gold B; Rodriguez WJ
    Pharmacotherapy; 1983; 3(2 Pt 1):82-100. PubMed ID: 6344037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ceftazidime in the treatment of severe localized and systemic infections.
    Gabrielli GB; Corrocher R; De Sandre G
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):167-9. PubMed ID: 6370875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials.
    Nix DE; DeVito JM
    Clin Pharm; 1987 Feb; 6(2):105-17. PubMed ID: 3311572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy.
    Jones ME; Karlowsky JA; Draghi DC; Thornsberry C; Sahm DF; Nathwani D
    Int J Antimicrob Agents; 2004 Mar; 23(3):240-6. PubMed ID: 15164964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cefsulodine concentrations in cerebral ventricles during parenteral treatment of ventriculitis due to Pseudomonas aeruginosa (author's transl)].
    Veyssier P; Dusehu E
    Nouv Presse Med; 1981 Oct; 10(35):2881-2. PubMed ID: 7290939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.